Table 5.
CHR | Nearest gene | COPDGene NHW | COPDGene AA | |||||
---|---|---|---|---|---|---|---|---|
All (n = 6658) | Cases (n = 2819) | Controls (n = 2534) | All (n = 3260) | Cases (n = 821) | Controls (n = 1749) | |||
Chromosome 15q25 | 15 | CHRNA3 | 0.17 | 0.24 | 0.41 | 0.52 | 0.52 | 0.49 |
15 | CHRNA5 | 0.06 | 0.15 | 1.00 | 0.30 | 0.33 | 0.45 | |
15 | AGPHD1 | 0.27 | 0.01 | 0.28 | 0.02 | 0.43 | 0.05 | |
15 | CHRNB4 | 0.87 | 0.82 | 0.84 | 0.87 | 0.19 | 0.50 | |
15 | IREB2 | 0.27 | 0.77 | 0.82 | 0.02 | NA | 0.15 | |
Replicated regions from the UK BiLEVE study | 1 | LPPR5 | 0.83 | 0.76 | 0.81 | 0.19 | 0.88 | 0.11 |
2 | TEX41/PABPC1P2 | 0.56 | 0.85 | 0.22 | 0.64 | 1.00 | 0.33 | |
6 | DNAH8 | 0.87 | 0.35 | 0.87 | 0.38 | 0.42 | 0.51 | |
7 | PDE1C | 1.00 | 0.05 | 0.14 | 0.60 | 0.32 | 0.74 | |
8 | CHRNB3 | 0.64 | 1.00 | 0.65 | 0.86 | NA | 1.00 | |
9 | DBH | 0.52 | 0.64 | 0.50 | 0.70 | 1.00 | 0.45 | |
10 | LOC100188947 | 0.87 | 0.79 | 0.71 | 0.11 | 0.51 | 0.69 | |
11 | BDNF | 1.00 | 0.76 | 0.46 | 0.26 | 0.48 | 0.56 | |
11 | NCAM1 | 0.76 | 0.30 | 0.82 | 0.03 | 0.27 | 0.28 | |
19 | RAB4B-EGLN2 | 0.44 | 0.69 | 0.57 | 0.04 | 0.15 | 0.27 | |
19 | CYP2A7 | 5.2E-4 | 0.05 | 0.08 | 0.47 | 0.51 | 0.97 | |
19 | CYP2B6 | 0.56 | 0.45 | 0.03 | 0.48 | 0.51 | 0.21 | |
20 | NOL4L | 0.32 | 0.55 | 0.89 | 0.84 | NA | NA |
AA = African American, CHR = chromosome, CPD = cigarettes per day, COPD = chronic obstructive pulmonary disorder, COPDGene = Genetic Epidemiology of COPD, NA = not applicable, NHW = non-Hispanic white. Correcting for the 12 regions listed, all p values less than 4.17E-3 (0.05/12) are in bold. NAs are given if there were not enough rare variants in the region for the test statistic.